Summary
A series of 320 German i.v. drug abusers (32.2% female, 67.8% male) were tested in a cross-sectional study for antibodies against HIV. Seroprevalence increased from 0 in those who discontinued i.v. drug abuse before 1982 to 37.2% in those who stopped injecting drugs in 1985/1986 or who were still addicted. Antibodies to HIV were significantly associated with lymphadenopathy and clinical symptoms (fever, weight loss, diarrhea, fatigue, night sweat, dermal lesions) and with markers of hepatitis A and hepatitis B virus infection.
Participants of the study admitted in 92.5% of cases to “needle sharing” and in 83.1% of cases to sexual contacts among drug abusers. Prostitution and drug abuse in prison were significantly correlated with seropositivity. No antibodies to HIV infection were detected in 131 subjects of a control group of household contacts.
Similar content being viewed by others
Abbreviations
- AIDS:
-
Acquired immunodeficiency syndrome
- CDC:
-
Centers for Disease Control
- DVV:
-
Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten
- ESR:
-
Erythrocyte sedimentation rate
- HIV:
-
Human immunodeficiency virus
References
Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O (1985) Rapid spread of HTLV-III among drug addicts in Italy. Lancet II:1302
Bienzle U, Guggenmoos-Holzmann I, Zwingenberger K, Thommsen R, Ritter K, Uy A, Bayer H, Schneider J, Hunsmann G, Coester CH, Kalden JR (1985) Lymphadenopathy and antibodies to HTLV-III in homosexual men. Klin Wochenschr 63:597–602
Brettle RP, Davidson J, Davidson SJ, Gray JMN, Inglis JM, Conn JS, Bath GE, Gillon J, McClelland DBL (1986) HTLV-III antibodies in an Edinburgh clinic. Lancet I:1009
Ferroni P, Geroldi D, Galli C, Zanetti AR, Cargnel A (1985) HTLV-III antibody among Italian drug addicts. Lancet II:52–53
Follet EAC, McIntyre A, O'Donnell B, Clements GB, Desselberger U (1986) HTLV-III antibody in drug abusers in the West of Scotland: the Edinburgh connection. Lancet I:446–447
Fuchs D, Blecha HG, Deinhardt F, Dierich MP, Goebel FD, Hengster P, Hinterhuber H, Schoenitzer D, Traill K, Wachter H (1985) High frequency of HTLV-III antibodies among heterosexual IV drug abusers in the Austrian Tyrol. Lancet I:1506
Hunsmann G, Schneider J, Bayer H, Kurth R, Werner A, Brede HD, Erfle V, Mellert W, Brodt HR, Bergmann L, Helm I, Scharrer I, Kreuz W, Berthold H, Wernet P, Schneider EM, Schimpf K, Egli U, Bienzle U, Schmitz H, Kern P, Krüger G, Rasokat H, Lechler E, Seifried E, Hellstern P, Schneider W, Holzer E, Goebel FD, Hehlmann R (1985) Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany. Klin Wochenschr 63:233–235
Köhler H, Lange W, Vettermann W, Pauli G, Koch MA (1985) Untersuchung auf LAV/HTLV-III Antikörper bei Insassen Berliner Haftanstalten mit Hepatitis Risiko. Bundesgesundhbl 11:328–329
Lange W, Masihi KN (1986) Durchsuchung mit Hepatitis B Virus bei Drogensüchtigen und Strafgefangenen in Berlin (West). Bundesgesundhbl 29:7–10
Melbye M, Ingerslev J, Biggar RJ, Alexander S, Sarin PS, Goerdert JJ, Zachariae E, Ebbesen P, Stenbjerg S (1985) Intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs. N Engl J Med 13:857
Mellenthin K (1985) Drogen und Prostitution. Gynäkologe 7:213–219
Mortimer PP, Vandervelde EM, Jesson WJ, Pereira MS, Burkhardt F (1985) HTLV-III antibody in Swiss and English intravenous drug abusers. Lancet II:449–450
Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE (1985) HTLV-III antibodies in Edinburgh drug addicts. Lancet I:1129–1130
Redfield RR, Markham PD, Salahuddin SZ, Sarngardharan MG, Bodner AJ, Folks TM, Ballou WR, Craig Wright D, Gallo R (1985) Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. JAMA 253:1571–1575
Rodrigo JM, Serra MA, Aguilar E, Del Olmo JA, Gimeno V, Aparisi L (1985) HTLV-III antibodies in drug addicts in Spain. Lancet II:156–157
Update (1986) Acquired immunodeficiency syndrome — United States. MMWR 35:17–21
Update (1986) Acquired immunodeficiency syndrome — Europe. MMWR 35:35–46
Wykoff RF (1985) Female to male transmission of AIDS agent. Lancet II:1017–1018
Zoulek G, Gürtler L, Eberle J, Lorbeer B, Deinhardt F (1986) Zunahme der Prävalenz von Antikörpern gegen LAV/HTLV-III bei Drogenabhängigen in der Bundesrepublik Deutschland. Dtsch Med Wochenschr 15:567–570
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harms, G., Laukamm-Josten, U., Bienzle, U. et al. Risk factors for HIV infection in german i.v. drug abusers. Klin Wochenschr 65, 376–379 (1987). https://doi.org/10.1007/BF01745578
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01745578